Bacterial Eye Infection Therapeutics Market to see Rapid Growth by 2029
Bacterial eye infection therapeutics market is anticipated to grow at a significant CAGR during the forecast period. The most prevalent bacterial infections of the eye include stye or sty (hordeolum), conjunctivitis keratitis, blepharitis, ocular herpes, uveitis, endophthalmitis, and cellulitis, among others. The rise in the geriatric patients’ population, coupled with the awareness about minor eye disorders are the pivotal factors affecting the growth of the global bacterial eye infection therapeutics market. The geriatric population is already considered to be more prone to suffer from eye diseases. Adding to this, there are high unmet medical needs related to eye care which are further anticipated to augment the global market growth.
Further, the incidences of bacterial eye infections
are projected to rise globally in the near future. The major causes of the same
include inadequate eye hygiene habits, an increasing number of post-operative
eye infections, coupled with the emergence of new pathogens. For instance, as
per the survey conducted by the National Ambulatory Medical Care Survey, alone
in the year 2005, over 4.0 million Americans made visits to ambulatory
physicians for bacterial conjunctivitis. Approximately 70% of patients with
acute conjunctivitis consult primary and urgent care providers, accounting for
1.0% of overall primary care office visits. Further, adenoviruses account for
65-90% of cases of viral conjunctivitis. In addition, the global incidence of
herpes simplex keratitis was calculated at approximately 1.5 million with
40,000 new cases of severe monocular visual impairment or blindness a year.
Some key players operating in the market include
Akorn, Inc., Novartis AG, and Bayer AG. These players are eyeing on
strengthening their position in the market by adopting various strategies as
mergers and acquisitions, partnerships, collaborations, new product launch and
development in the existing product portfolio, and so on.
To Request a Sample of our Report on Bacterial Eye
Infection Therapeutics Market: https://www.omrglobal.com/request-sample/bacterial-eye-infection-therapeutics-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Akorn, Inc., Novartis
AG, and Bayer AG.
Bacterial Eye Infection Therapeutics Market - Segmentation
By Product
• Ointments
• Eye Drops
• Drugs
A
full Report of Bacterial Eye Infection Therapeutics Market is Available
at: https://www.omrglobal.com/industry-reports/bacterial-eye-infection-therapeutics-market
Bacterial Eye Infection Therapeutics Market Segmentation by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment